British Dragon Anastrozole contains 1 mg of Anastrozole per tablet and is designed for precise oral dosing. For low-dose tablet products, independent lab testing is especially valuable because even small variations can matter, making potency verification an important part of product transparency.
Below is the latest available lab test confirming the potency of Anastrozole 1 mg, conducted by a trusted third-party laboratory.
Latest Lab Result (2026)
Janoshik Lab Report – 2026-03-23
- Product: Anastrozole
- Active Substance: Anastrozole
- Manufacturer: British Dragon
- Labeled Dosage: 1 mg/tablet
- Result: 0.96 mg/tablet
- Laboratory: Janoshik
This lab test shows a measured content of 0.96 mg per tablet, which is very close to the labeled 1 mg dosage. The result indicates good formulation accuracy with only a small negative deviation.
Potency Analysis
- Labeled dosage: 1 mg
- Measured dosage: 0.96 mg
- Deviation: ~-4%
- Laboratory: Janoshik
The measured result shows only a minor deviation from the labeled dosage, which remains within a tight range for a low-dose tablet formulation.
About Anastrozole
Anastrozole is an aromatase inhibitor commonly produced in low-dose oral tablet form, where manufacturing precision is especially important. Because each tablet contains only a small amount of active substance, independent testing provides helpful confirmation of real-world dosage accuracy.
Lab verification supports transparency and helps evaluate whether a batch remains close to its intended formulation.
Conclusion
The available lab test for British Dragon Anastrozole 1 mg shows a measured dosage of 0.96 mg per tablet, which is very close to the labeled amount. This result reflects good formulation accuracy and a tight variance for a low-dose tablet product.
As a newly tested batch, additional lab reports over time would provide a broader picture of long-term consistency. However, this initial result already indicates a reliable potency profile.
Frequently Asked Questions
Yes, the available lab test shows 0.96 mg per tablet, which is very close to the labeled 1 mg dosage.
The result shows only a small deviation of about 4%, which indicates good accuracy for a low-dose tablet formulation.
The available lab report was conducted by Janoshik, an independent laboratory.
Currently, only one lab test is available. Additional reports would help show long-term batch consistency.
